Acute depression is associated with impaired self-referential processing. Antidepressant effects on the neural bases of self-referential processing in depression are unknown. This study aimed to assess shortand long-term effects of agomelatine on these neural bases in depressed patients and the association between pre-treatment brain activation and remission of depression 6 months later. We conducted a randomized double-blind, placebo-controlled, functional magnetic resonance imaging (fMRI) study during an emotional self-referential task, including three scanning sessions (baseline, after 1 week, and after 7 weeks). Twenty-five depressed outpatients were included, all treated with agomelatine or placebo for 1 week. Then, all patients received agomelatine for 24 weeks. Fourteen matched healthy volunteers (HV) who received placebo for 1 week were also included. After 7 days, only depressed patients receiving agomelatine significantly deactivated the ventrolateral prefrontal cortex during self-referential processing, as observed in HV at baseline. After 7 weeks, depressed patients significantly increased the activation of the ventral anterior cingulate cortex. Finally dorsomedial prefrontal cortex and precuneus activations at baseline significantly separated remitters from non-remitters at 24 weeks. In depressed patients, agomelatine had short-and long-term effects on brain structures involved in anhedonia and emotional regulation during self-referential processing. Activation of the dorsomedial prefrontal cortex and precuneus could be informative in the development of biomarker-based treatment of major depression.
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Introduction
Major depressive disorder (MDD) is associated with several biases in information processing. Depressed patients prioritize the processing of negative emotional information and show increased attention to the self, namely self-focus (Mor and Winquist, 2002) . Increased self-focus in depressed patients involves the cortical midline structures, including the medial prefrontal cortex (MPFC) and the posterior cingulate cortex (PCC) (Lemogne et al., 2009 (Lemogne et al., , 2012 Yoshimura et al., 2010; Nejad et al., 2013) , as well as the dorsolateral prefrontal cortex (DLPFC; Lemogne et al., 2009) .
There is growing interest in the effects of antidepressant drugs on such biases as they play a key role in the initiation and maintenance of depressive symptoms (Harmer et al., 2003 (Harmer et al., , 2004 (Harmer et al., , 2009 Pringle et al., 2011) . On one hand, one pilot study showed that long-term administration of antidepressants in depressed patients modulates the activity of the DLPFC during self-processing (Lemogne et al., 2010 
